Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-06

FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited under ANDA090401, indicating an updated or added approval for this generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)